P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1

Detalles Bibliográficos
Autores principales: Popat, R., Moreau, P., Usmani, S. Z., Garfall, A., Mateos, M.-V., San-Miguel, J. F., Oriol, A., Nooka, A. K., Rosinol, L., Chari, A., Karlin, L., Krishnan, A., Bahlis, N., Martin, T., Besemer, B., Martínez-López, J., Delforge, M., Fastenau, J., Gries, K. S., van de Donk, N. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431097/
http://dx.doi.org/10.1097/01.HS9.0000846556.04927.df
_version_ 1784779959008493568
author Popat, R.
Moreau, P.
Usmani, S. Z.
Garfall, A.
Mateos, M.-V.
San-Miguel, J. F.
Oriol, A.
Nooka, A. K.
Rosinol, L.
Chari, A.
Karlin, L.
Krishnan, A.
Bahlis, N.
Martin, T.
Besemer, B.
Martínez-López, J.
Delforge, M.
Fastenau, J.
Gries, K. S.
van de Donk, N. W.
author_facet Popat, R.
Moreau, P.
Usmani, S. Z.
Garfall, A.
Mateos, M.-V.
San-Miguel, J. F.
Oriol, A.
Nooka, A. K.
Rosinol, L.
Chari, A.
Karlin, L.
Krishnan, A.
Bahlis, N.
Martin, T.
Besemer, B.
Martínez-López, J.
Delforge, M.
Fastenau, J.
Gries, K. S.
van de Donk, N. W.
author_sort Popat, R.
collection PubMed
description
format Online
Article
Text
id pubmed-9431097
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94310972022-08-31 P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1 Popat, R. Moreau, P. Usmani, S. Z. Garfall, A. Mateos, M.-V. San-Miguel, J. F. Oriol, A. Nooka, A. K. Rosinol, L. Chari, A. Karlin, L. Krishnan, A. Bahlis, N. Martin, T. Besemer, B. Martínez-López, J. Delforge, M. Fastenau, J. Gries, K. S. van de Donk, N. W. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431097/ http://dx.doi.org/10.1097/01.HS9.0000846556.04927.df Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Popat, R.
Moreau, P.
Usmani, S. Z.
Garfall, A.
Mateos, M.-V.
San-Miguel, J. F.
Oriol, A.
Nooka, A. K.
Rosinol, L.
Chari, A.
Karlin, L.
Krishnan, A.
Bahlis, N.
Martin, T.
Besemer, B.
Martínez-López, J.
Delforge, M.
Fastenau, J.
Gries, K. S.
van de Donk, N. W.
P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1
title P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1
title_full P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1
title_fullStr P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1
title_full_unstemmed P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1
title_short P922: HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1
title_sort p922: health-related quality of life with teclistamab, a b-cell maturation antigen x cd3 bispecific antibody, in patients with relapsed/refractory multiple myeloma from majestec-1
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431097/
http://dx.doi.org/10.1097/01.HS9.0000846556.04927.df
work_keys_str_mv AT popatr p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT moreaup p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT usmanisz p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT garfalla p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT mateosmv p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT sanmigueljf p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT oriola p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT nookaak p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT rosinoll p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT charia p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT karlinl p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT krishnana p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT bahlisn p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT martint p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT besemerb p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT martinezlopezj p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT delforgem p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT fastenauj p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT griesks p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1
AT vandedonknw p922healthrelatedqualityoflifewithteclistamababcellmaturationantigenxcd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomafrommajestec1

Ejemplares similares